Join the club for FREE to access the whole archive and other member benefits.


Company developing multi-path therapeutics for age-related disorders via activating adult stem cells

Centagen develops protocols and techniques for expanding AS cells in the patient's body or for expanding a patient's AS cells some million fold in special stem cell incubators while preventing cell aging or functional loss. In developing incubator stem cell techniques, Centagen will be able to remove AS cells from a patient in a doctor's office visit, isolate and expand their own AS cells in the cell incubator for several weeks without aging or changing them, and then return the expanded AS cell population to the patient. We are also developing the technology to return AS cells to a more youthful state. The source of AS cells can be from whole blood, bone marrow, belly fat, facial or body skin, nasal passage, hair follicle, or dental tissue. Returning the greatly expanded adult stem cell population back to the patient has the potential to regenerating many tissues and organs. Many off-shore clinics are already providing patients with some AS services and Centagen could greatly help these clinics by expanding their patients' AS cells to greatly enhance AS therapeutic efficacy. Our proprietary technology is furthest along using AS cells from blood, which can form into many end tissues in blood vessels, bone, cartilage, immune system, retina, kidney, and heart.

Visit website:

Details last updated 23-Apr-2020

People at Centagen

Bryant Villeponteau

President and CSO of Centagen.

Centagen News

Organ, tissue replacement could end aging by mid-2020s

Institute for Ethics and Emerging Technologies (IEET) - 14-May-2013

Topics mentioned on this page:
Stem Cells